VQ-SAP is a specialized triterpenoid saponin raw material derived from the inner bark of Quillaja saponaria Molina, commonly known as the Chilean Soapbark tree. It is specifically developed for applications where a high-quality Quillaja saponin source is required, especially in pharmaceutical and veterinary vaccine development. With its industry-leading concentration profile, VQ-SAP is ideally suited as a precursor for isolating Pharma-grade QS-21 and QS-7, making it a valuable input for advanced adjuvant research and formulation workflows. For manufacturers and R&D teams working in vaccine adjuvant development, VQ-SAP offers a reliable botanical source matrix with strong relevance in high-value biopharmaceutical processes. Its composition and origin make it particularly suitable for downstream purification and extraction processes where consistency, purity control, and sourcing reliability are critical. In veterinary health applications, VQ-SAP serves as a high-efficiency precursor for next-generation vaccine formulations, supporting the development of advanced animal health products. As a B2B supply item, VQ-SAP is best positioned for pharmaceutical companies, biotech firms, veterinary vaccine developers, and research institutions seeking a dependable Quillaja-derived saponin ingredient. Its strength lies in its use as an upstream raw material for specialized extraction, not as a consumer-facing finished product. This makes it highly relevant for bulk procurement, formulation research, and industrial-scale processing in regulated environments. SEO-focused relevance: Quillaja saponin, Quillaja saponaria bark extract, triterpenoid saponins, QS-21 precursor, QS-7 precursor, veterinary vaccine adjuvant raw material, Pharma-grade saponin source, and Quillaja bark inner extract are highly relevant search terms for this product.
Key Features
| Features | Description |
|---|---|
| Botanical Source | Derived from the inner bark of Quillaja saponaria Molina (Chilean Soapbark tree) |
| Saponin Class | Triterpenoid saponins |
| Primary Application | Ideal raw material for isolating Pharma-grade QS-21 and QS-7 |
| Veterinary Use | High-efficiency precursor for veterinary vaccine adjuvant formulations |
| Industry Positioning | Specialized B2B ingredient for pharma, biotech, and animal health applications |
| Attributes | Description |
|---|---|
| Product Title | VQ-SAP |
| Store Name | Swasti Exports |
| MOQ | 1 |
| Botanical Origin | Inner bark of Quillaja saponaria Molina |
| Common Name | Chilean Soapbark tree |
| Compound Class | Triterpenoid saponins |
| Key Active Targets | QS-21 and QS-7 |
| Intended Application | Pharmaceutical and veterinary adjuvant processing |
| Product Form | Botanical raw material / extraction input |
*Disclaimer: The above description has been AI-generated and has not been audited or verified for accuracy. It is recommended to verify product details independently before making any purchasing decisions.
VQ-SAP is derived from the inner bark of Quillaja saponaria and is positioned as a high-concentration triterpenoid saponin source, making it suitable as an upstream raw material for isolating Pharma-grade QS-21 and QS-7.
VQ-SAP is a precursor material, not a finished adjuvant. It is intended for downstream extraction, purification, and formulation workflows in pharma and veterinary applications.
VQ-SAP is primarily relevant to pharmaceutical companies, biotechnology firms, veterinary vaccine developers, and research organizations involved in adjuvant development.
The inner bark of Quillaja saponaria is the natural botanical source of the triterpenoid saponins used in advanced extraction processes, making it a preferred feedstock for specialized applications.
Yes, VQ-SAP is described as a high-efficiency precursor for advanced animal health vaccine formulations, especially where Quillaja-derived adjuvant components are required.
Inclusive of all taxes
You Save: 0
Vadodara , India
Manufacturer, Trader, Exporter, Importer
GST- 24AIXPB0733C1ZO
Trust Mark
